Are Allergy Drops Covered by Insurance? 2026 Costs Compared

Because of their regulatory status, not because they are thought not to work. A small number of SLIT tablets and OIT products are FDA-approved for specific allergens; personalized allergy drops are compounded by pharmacies and prescribed off-label — a long-standing, legitimate practice with decades of use (and SLIT is a first-line prescription approach in much of Europe). But drops are created using FDA-approved allergenic extracts, the same as in allergy shots. Off-label does not mean unsafe or experimental. Insurers, including commercial plans, Medicare and Medicaid, routinely exclude off-label products, so the drops are usually self-pay whichever plan you have.

Insurance often covers testing, consultations and in-office allergy shots; compounded drops are generally out-of-pocket. Skin or blood allergy testing and the specialist visit that reviews it are billed to your medical benefit like other diagnostic care, subject to your deductible and copay. Allergy shots are covered by most commercial plans and by Medicare Part B, which in 2026 pays nationally $17.37 per dose of extract (CPT 95165) and $10.35 to $12.36 per injection visit (CPT 95115/95117), before geographic adjustment. FDA-approved sublingual tablets go through your prescription benefit and often need prior authorization.

Usually yes. Prescribed allergy treatment generally counts as a qualified medical expense under IRS Publication 502, so you can typically pay for allergy drops with pre-tax Health Savings Account or Flexible Spending Account money, which lowers the real cost by your marginal tax rate. Keep your prescription and receipts in case your administrator asks for them, and check first if you have a limited-purpose FSA, which may cover only dental and vision.

Often, yes. Grastek (timothy grass), Oralair (five grasses), Ragwitek (short ragweed) and Odactra (house dust mite) are FDA-approved prescription drugs, so many commercial plans cover them, usually after prior authorization, and some Medicare Part D plans list them. Without insurance, drugs.com listed cash prices from $287.12 for 30 tablets of Grastek or Ragwitek, $367.51 for Odactra and $435.38 for Oralair (as read on 2026-09-28). The manufacturer of Grastek, Ragwitek and Odactra advertises a savings program. Each tablet treats one allergen, which matters if you react to several.

As published on their own websites on 2026-09-28: Wyndly from $99 a month (12-month membership $1,200; testing included); Quello $297 a quarter or $999 a year (testing and first consultation free); Nectar from $79 a month on a 3-year plan or $99 a month on a 1-year plan; Aspire Allergy & Sinus $297 a quarter, $950 a year or $2,350 for 3 years (testing billed separately); HeyAllergy from $47 a month. Each has strengths: Wyndly publishes a 90-day money-back guarantee, Quello includes testing and unlimited follow-up visits, Nectar and Aspire offer longer prepaid plans, and HeyAllergy lists the lowest starting price. None of these providers says its drops are covered by insurance. Curex: see current plans at getcurex.com/pricing.

Less than you might expect for the drops, and more for everything else. Because the exclusion follows the drops' off-label status, Aetna, Cigna, Blue Cross Blue Shield, UnitedHealthcare, Medicare and most Medicaid programs generally do not pay for compounded drops. Plans differ on testing, specialist copays, allergy shots and whether FDA-approved tablets need prior authorization, so check those details with your plan.